Heparin reexposure in patients with a history of heparin-induced thrombocytopenia

Prajwal Dhakal, Smith Giri, Ranjan Pathak, Vijaya R Bhatt

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objectives: Patients with a history of heparin-induced thrombocytopenia (HIT), who require subsequent anticoagulation, have limited options. Rechallenge with unfractionated heparin (UFH) has been reported but may be associated with a risk of recurrence of HIT. The objective of this study was to determine the safety of heparin reexposure in patients with a history of HIT. Methods: Using several search terms, all cases of heparin reexposure in patients with HIT indexed in MEDLINE (English language only) by June 2014 were reviewed. The bibliography of each relevant article was searched for additional reports. In cases of multiple reexposures, each reexposure was identified as a separate instance of reexposure during analysis. Results: A total of 136 patients with a history of HIT had 141 instances of heparin reexposure. Cardiac (76%) and vascular surgeries (11%) were the most common indications. Antiplatelet factor 4/heparin antibodies were positive in 63% of evaluable cases before reexposure. Preexposure plasma exchange (11%) and postexposure nonheparin anticoagulants (63%) were frequently utilized. Complications with heparin reexposure included recurrence of HIT (2.1%, 95% confidence interval 0.73%-6.07%) and bleeding (2.1%). Conclusion: Intraoperative heparin reexposure in patients with a history of HIT has a small risk of developing HIT recurrence. The use of preexposure plasma exchange in patients with positive antiplatelet factor 4/heparin antibody and postexposure nonheparin anticoagulants arguably may have reduced the risk of recurrence of HIT.

Original languageEnglish (US)
Pages (from-to)626-631
Number of pages6
JournalClinical and Applied Thrombosis/Hemostasis
Volume21
Issue number7
DOIs
StatePublished - Oct 5 2015

Fingerprint

Thrombocytopenia
Heparin
Recurrence
Plasma Exchange
Anticoagulants
Antibodies
Bibliography
MEDLINE
Blood Vessels

Keywords

  • heparin-induced thrombocytopenia
  • low-molecular-weight heparin
  • nonheparin anticoagulant
  • plasma exchange
  • reexposure
  • unfractionated heparin

ASJC Scopus subject areas

  • Hematology

Cite this

Heparin reexposure in patients with a history of heparin-induced thrombocytopenia. / Dhakal, Prajwal; Giri, Smith; Pathak, Ranjan; Bhatt, Vijaya R.

In: Clinical and Applied Thrombosis/Hemostasis, Vol. 21, No. 7, 05.10.2015, p. 626-631.

Research output: Contribution to journalArticle

@article{aec38643990647e5a7af774ea946e83d,
title = "Heparin reexposure in patients with a history of heparin-induced thrombocytopenia",
abstract = "Objectives: Patients with a history of heparin-induced thrombocytopenia (HIT), who require subsequent anticoagulation, have limited options. Rechallenge with unfractionated heparin (UFH) has been reported but may be associated with a risk of recurrence of HIT. The objective of this study was to determine the safety of heparin reexposure in patients with a history of HIT. Methods: Using several search terms, all cases of heparin reexposure in patients with HIT indexed in MEDLINE (English language only) by June 2014 were reviewed. The bibliography of each relevant article was searched for additional reports. In cases of multiple reexposures, each reexposure was identified as a separate instance of reexposure during analysis. Results: A total of 136 patients with a history of HIT had 141 instances of heparin reexposure. Cardiac (76{\%}) and vascular surgeries (11{\%}) were the most common indications. Antiplatelet factor 4/heparin antibodies were positive in 63{\%} of evaluable cases before reexposure. Preexposure plasma exchange (11{\%}) and postexposure nonheparin anticoagulants (63{\%}) were frequently utilized. Complications with heparin reexposure included recurrence of HIT (2.1{\%}, 95{\%} confidence interval 0.73{\%}-6.07{\%}) and bleeding (2.1{\%}). Conclusion: Intraoperative heparin reexposure in patients with a history of HIT has a small risk of developing HIT recurrence. The use of preexposure plasma exchange in patients with positive antiplatelet factor 4/heparin antibody and postexposure nonheparin anticoagulants arguably may have reduced the risk of recurrence of HIT.",
keywords = "heparin-induced thrombocytopenia, low-molecular-weight heparin, nonheparin anticoagulant, plasma exchange, reexposure, unfractionated heparin",
author = "Prajwal Dhakal and Smith Giri and Ranjan Pathak and Bhatt, {Vijaya R}",
year = "2015",
month = "10",
day = "5",
doi = "10.1177/1076029615578167",
language = "English (US)",
volume = "21",
pages = "626--631",
journal = "Clinical and Applied Thrombosis/Hemostasis",
issn = "1076-0296",
publisher = "SAGE Publications Inc.",
number = "7",

}

TY - JOUR

T1 - Heparin reexposure in patients with a history of heparin-induced thrombocytopenia

AU - Dhakal, Prajwal

AU - Giri, Smith

AU - Pathak, Ranjan

AU - Bhatt, Vijaya R

PY - 2015/10/5

Y1 - 2015/10/5

N2 - Objectives: Patients with a history of heparin-induced thrombocytopenia (HIT), who require subsequent anticoagulation, have limited options. Rechallenge with unfractionated heparin (UFH) has been reported but may be associated with a risk of recurrence of HIT. The objective of this study was to determine the safety of heparin reexposure in patients with a history of HIT. Methods: Using several search terms, all cases of heparin reexposure in patients with HIT indexed in MEDLINE (English language only) by June 2014 were reviewed. The bibliography of each relevant article was searched for additional reports. In cases of multiple reexposures, each reexposure was identified as a separate instance of reexposure during analysis. Results: A total of 136 patients with a history of HIT had 141 instances of heparin reexposure. Cardiac (76%) and vascular surgeries (11%) were the most common indications. Antiplatelet factor 4/heparin antibodies were positive in 63% of evaluable cases before reexposure. Preexposure plasma exchange (11%) and postexposure nonheparin anticoagulants (63%) were frequently utilized. Complications with heparin reexposure included recurrence of HIT (2.1%, 95% confidence interval 0.73%-6.07%) and bleeding (2.1%). Conclusion: Intraoperative heparin reexposure in patients with a history of HIT has a small risk of developing HIT recurrence. The use of preexposure plasma exchange in patients with positive antiplatelet factor 4/heparin antibody and postexposure nonheparin anticoagulants arguably may have reduced the risk of recurrence of HIT.

AB - Objectives: Patients with a history of heparin-induced thrombocytopenia (HIT), who require subsequent anticoagulation, have limited options. Rechallenge with unfractionated heparin (UFH) has been reported but may be associated with a risk of recurrence of HIT. The objective of this study was to determine the safety of heparin reexposure in patients with a history of HIT. Methods: Using several search terms, all cases of heparin reexposure in patients with HIT indexed in MEDLINE (English language only) by June 2014 were reviewed. The bibliography of each relevant article was searched for additional reports. In cases of multiple reexposures, each reexposure was identified as a separate instance of reexposure during analysis. Results: A total of 136 patients with a history of HIT had 141 instances of heparin reexposure. Cardiac (76%) and vascular surgeries (11%) were the most common indications. Antiplatelet factor 4/heparin antibodies were positive in 63% of evaluable cases before reexposure. Preexposure plasma exchange (11%) and postexposure nonheparin anticoagulants (63%) were frequently utilized. Complications with heparin reexposure included recurrence of HIT (2.1%, 95% confidence interval 0.73%-6.07%) and bleeding (2.1%). Conclusion: Intraoperative heparin reexposure in patients with a history of HIT has a small risk of developing HIT recurrence. The use of preexposure plasma exchange in patients with positive antiplatelet factor 4/heparin antibody and postexposure nonheparin anticoagulants arguably may have reduced the risk of recurrence of HIT.

KW - heparin-induced thrombocytopenia

KW - low-molecular-weight heparin

KW - nonheparin anticoagulant

KW - plasma exchange

KW - reexposure

KW - unfractionated heparin

UR - http://www.scopus.com/inward/record.url?scp=84940833557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940833557&partnerID=8YFLogxK

U2 - 10.1177/1076029615578167

DO - 10.1177/1076029615578167

M3 - Article

C2 - 25804614

AN - SCOPUS:84940833557

VL - 21

SP - 626

EP - 631

JO - Clinical and Applied Thrombosis/Hemostasis

JF - Clinical and Applied Thrombosis/Hemostasis

SN - 1076-0296

IS - 7

ER -